At a Glance: March's Hottest IPOs - Shangmi Technology Approved! Four New Stocks, Including ZhaoWei Electromechanical and EastControl, Undergoing Enthusiastic Subscription.

Hello, fellow investors! The New Stock Observer is here to provide updates on the popular HK IPOs in March and throughout 2026. Fellow investors, check it out now!

Futu NewsFeb 28 09:55

ImmVira's Oncolytic Product MVR-T3011 Expanded to BCG-Naïve Bladder Cancer Patients for the First Time With Clinical Data Presented at the 2026 ASCO GU Conference

PR NewswireFeb 27 08:00

Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

PR NewswireFeb 5 06:31

Hong Kong Stock IPO Weekly Report | Multiple companies, including Jiehua Technology, filed for listing en masse; GigaDevice's debut week saw a nearly 70% surge.

According to Livermore Securities, this week (January 12th to January 18th), 24 companies submitted listing applications to the Hong Kong Stock Exchange, three companies passed the hearing, one company started its initial public offering, and four new stocks were listed.

cls.cnJan 18 16:39

The First Company to Have Its Review Deferred in 2026 | Key Developments in IPOs This Week

In the past week, IPO activities in both domestic and overseas capital markets have been frequent, kicking off an active year. Zhejiang Xinseng Technology Co., Ltd.'s IPO was postponed on the day of its review, marking the first deferred IPO case in the Shanghai, Shenzhen, and Beijing exchanges in 2026. The Hong Kong IPO market has continued its vibrant start to the year, with 20 companies submitting listing applications to the Hong Kong Stock Exchange in quick succession. These companies span various high-growth sectors such as consumer retail, semiconductors, biomedicine, agriculture, animal husbandry, and logistics. Both advanced technology and consumer-driven industries are driving momentum, showcasing Hong Kong's appeal to quality enterprises while reflecting capital markets' preference for leading players in niche fields.

China InvestorsJan 18 08:01

ImmVira-B has submitted its IPO prospectus and plans to go public in Hong Kong, with Citi and CICC acting as joint sponsors.

ImmVira-B has submitted its IPO prospectus and plans to go public in Hong Kong, with Citi and CICC acting as joint sponsors.

Ryanben CapitalJan 15 13:43